“Mini-Me” is one of the only two Greek projects to have secured funding as coordinators from the highly competitive EIC Pathfinder Open program of the European Innovation Council.

The selection of this project from among 2,103 proposals from 30 countries for the EIC Pathfinder Open program represents a significant achievement for Greek biomedical research, especially given the intense competition, which saw a success rate of approximately 2%.

The project “Mini Proteins against Mega Diseases” (Mini-Me) scientifically coordinated by Dr. George Skretas, Principal Investigator & Coordinator of Twin4Promis and Director of the Institute of Bioinnovation at the BSRC “Alexander Fleming aims to break new ground in therapeutic research for diseases caused by misfolding proteins, by developing a radically new technology.

The consortium comprises eight partners from six European countries, including two partners from Twin4Promis training hub in protein misfolding diseases, the advanced partner Michele Vendruscolo from the University of Cambridge and the Greek biotechnology company ResQ Biotech, which plays a pivotal role in the exploitation of the technology and the future development of therapeutic applications. The Hub’s role is to bridge the gap between the communities that study the misfolding of soluble and integral membrane proteins.

The European Innovation Council (EIC) has selected 43 groundbreaking projects under the EIC Pathfinder Open 2026 call, each of them receiving up to €4 million in grant funding. From pioneering cancer treatments and quantum computing to advanced manufacturing and climate-resilient technologies, these projects aim to push the boundaries of scientific discovery and lay the foundations for tomorrow’s breakthrough innovations.

“Mini-Me” was the third in the list of selected projects

Read the full story in ATHENS-MACEDONIAN News Agency